Kiniksa Pharmaceuticals Ltd (KNSA) — Working Capital to Net Assets Ratio
Kiniksa Pharmaceuticals Ltd (KNSA) has a Working Capital to Net Assets ratio of 76.0% as of June 2026. Working capital of $497.39 Million (current assets of $668.63 Million minus current liabilities of $171.25 Million) is measured against net assets of $654.15 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See operational self-sufficiency of Kiniksa Pharmaceuticals Ltd to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kiniksa Pharmaceuticals Ltd Working Capital to Net Assets (2016–2025)
This chart shows how Kiniksa Pharmaceuticals Ltd's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 76.0%, reflecting working capital of $497.39 Million against net assets of $654.15 Million USD. For the complete balance sheet picture, see balance sheet size of Kiniksa Pharmaceuticals Ltd.
Annual Working Capital to Net Assets for Kiniksa Pharmaceuticals Ltd (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kiniksa Pharmaceuticals Ltd from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Kiniksa Pharmaceuticals Ltd's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 68.4% | $387.99 Million | $567.61 Million | $527.18 Million | $139.18 Million | ▲ +15.6 pp |
| 2024 | 52.7% | $231.18 Million | $438.44 Million | $331.80 Million | $100.62 Million | ▲ +4.3 pp |
| 2023 | 48.5% | $212.63 Million | $438.84 Million | $276.30 Million | $63.67 Million | ▼ -1.0 pp |
| 2022 | 49.5% | $195.99 Million | $396.15 Million | $243.06 Million | $47.07 Million | ▼ -32.5 pp |
| 2021 | 81.9% | $151.62 Million | $185.04 Million | $196.45 Million | $44.82 Million | ▼ -14.7 pp |
| 2020 | 96.6% | $301.40 Million | $311.94 Million | $333.25 Million | $31.85 Million | ▲ +1.8 pp |
| 2019 | 94.8% | $213.80 Million | $225.42 Million | $241.63 Million | $27.83 Million | ▼ -2.3 pp |
| 2018 | 97.1% | $271.20 Million | $279.27 Million | $313.75 Million | $42.55 Million | ▲ +130.2 pp |
| 2017 | -33.1% | $29.67 Million | $-89.71 Million | $47.10 Million | $17.43 Million | ▲ +176.9 pp |
| 2016 | -210.0% | $54.03 Million | $-25.73 Million | $56.33 Million | $2.30 Million | — |